Restless Legs Syndrome

被引:26
作者
Venkateshiah, Saiprakash B. [1 ]
Ioachimescu, Octavian C. [1 ]
机构
[1] Emory Univ, Sch Med, Dept Med, Div Pulm Crit Care & Sleep Med, Atlanta, GA USA
关键词
Restless legs syndrome; Periodic leg movements of sleep; Iron deficiency; Dopaminergic agents; Alpha-2-delta calcium channel ligands; Opioid agents; PERIODIC LIMB MOVEMENTS; BRAIN IRON ACQUISITION; VASCULAR RISK-FACTORS; CARDIOVASCULAR-DISEASE; CLINICAL CHARACTERISTICS; TYROSINE-HYDROXYLASE; CELIAC-DISEASE; SLEEP; PREVALENCE; PATHOPHYSIOLOGY;
D O I
10.1016/j.ccc.2015.03.003
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Restless legs syndrome is a common sensorimotor disorder characterized by an urge to move, and associated with uncomfortable sensations in the legs (limbs). Restless legs syndrome can lead to sleep-onset or sleep-maintenance insomnia, and occasionally excessive daytime sleepiness, all leading to significant morbidity. Brain iron deficiency and dopaminergic neurotransmission abnormalities play a central role in the pathogenesis of this disorder, along with other nondopaminergic systems, although the exact mechanisms are still. Intensive care unit patients are especially vulnerable to have unmasking or exacerbation of restless legs syndrome because of sleep deprivation, circadian rhythm disturbance, immobilization, iron deficiency, and use of multiple medications that can antagonize dopamine.
引用
收藏
页码:459 / +
页数:15
相关论文
共 101 条
[11]   Restless legs syndrome prevalence and impact - REST general population study [J].
Allen, RP ;
Walters, AS ;
Montplaisir, J ;
Hening, W ;
Myers, A ;
Bell, TJ ;
Ferini-Strambi, L .
ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (11) :1286-1292
[12]   Increased CSF hypocretin-1 (orexin-A) in restless legs syndrome [J].
Allen, RP ;
Mignot, E ;
Ripley, B ;
Nishino, S ;
Earley, CJ .
NEUROLOGY, 2002, 59 (04) :639-641
[13]   MRI measurement of brain iron in patients with restless legs syndrome [J].
Allen, RP ;
Barker, PB ;
Wehrl, F ;
Song, HK ;
Earley, CJ .
NEUROLOGY, 2001, 56 (02) :263-265
[14]  
[Anonymous], DOPAMINE BEHAV STATE
[15]  
[Anonymous], EFFECTS OPIATES NIGR
[16]  
[Anonymous], DE ANIMA BRUTORUM
[17]  
[Anonymous], 2011, Iran J Crit Care Nurs
[18]  
Aurora RN, 2012, SLEEP, V35, P1039, DOI 10.5665/sleep.1988
[19]  
Banerji N K, 1970, Br Med J, V4, P774
[20]  
BEARD JL, 1993, NUTR REV, V51, P157, DOI 10.1111/j.1753-4887.1993.tb03096.x